MARKET

NNVC

NNVC

Nanoviricides
AMEX
1.485
+0.085
+6.07%
Opening 11:12 10/07 EDT
OPEN
1.455
PREV CLOSE
1.400
HIGH
1.500
LOW
1.400
VOLUME
164.26K
TURNOVER
--
52 WEEK HIGH
2.230
52 WEEK LOW
0.8500
MARKET CAP
37.90M
P/E (TTM)
-3.6478
1D
5D
1M
3M
1Y
5Y
1D
NanoViricides says Phase II trial of NV-387 in ebola ‘proceeding as designed’
TipRanks · 2d ago
NanoViricides Updates Phase II Trial Of NV-387 Oral Gummies For Ebola Treatment In DRC; Reports Cautious Early Enrollment
Benzinga · 2d ago
Weekly Report: what happened at NNVC last week (0928-1002)?
Weekly Report · 2d ago
NanoViricides Provides Additional Details on the Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola as the Outbreak Continues to Expand and Has Taken Over 4,000 Lives
Barchart · 2d ago
NanoViricides ‘actively exploring’ additional required funding
TipRanks · 09/29 12:56
NanoViricides reports FY26 EPS (41c) vs. (63c) last year
TipRanks · 09/29 12:50
NanoViricides, Inc. Has Filed its Annual Report: Broad-spectrum Antiviral NV-387 Is In Phase II Clinical Trials
Barchart · 09/29 07:45
Nanoviricides Q4 EPS $(0.10), Inline
Benzinga · 09/28 21:47
More
About NNVC
NanoViricides, Inc. is a clinical-stage company. The Company is engaged in developing a class of drugs that it calls nanoviricides, using a platform technology based on the application of nanomedicine technologies to the complex issues of viral diseases. Its lead drug candidate is NV-387, a broad-spectrum antiviral drug that has demonstrated activity in lethal lung infection animal model studies of Coronavirus (COVID), Respiratory Syncytial Virus, Influenza, Orthopoxvirus model for Smallpox and MPox, and even in a humanized mice model for Measles. It is focused on advancing Phase II clinical trials. Its other advanced drug candidate is NV-HHV-1 for the treatment of Shingles rash. Its NV-CoV-2 and NV-CoV-2-R are drug candidates for the treatment of COVID. Its portfolio also includes NV-HIV-1, a novel mechanism Anti-HIV Drug Candidate. Its other drug candidates include treatment for viral infections, including Dengue viruses, Ebola viruses, among others.

Webull offers NanoViricides, Inc stock information, including AMEX: NNVC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NNVC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NNVC stock methods without spending real money on the virtual paper trading platform.